NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,829,081 | -3.3% | 47,409 | -4.2% | 0.19% | +1.1% |
| Q2 2023 | $4,993,531 | +14.8% | 49,485 | +4.7% | 0.19% | +8.7% |
| Q1 2023 | $4,349,944 | +6.2% | 47,282 | +4.7% | 0.17% | +3.0% |
| Q4 2022 | $4,097,097 | +16.0% | 45,162 | -2.8% | 0.17% | +5.7% |
| Q3 2022 | $3,531,000 | -11.4% | 46,450 | -1.5% | 0.16% | -6.5% |
| Q2 2022 | $3,985,000 | -4.3% | 47,138 | -0.7% | 0.17% | +7.6% |
| Q1 2022 | $4,164,000 | -0.8% | 47,455 | -1.1% | 0.16% | +0.6% |
| Q4 2021 | $4,199,000 | +2.1% | 48,001 | -4.6% | 0.16% | -9.8% |
| Q3 2021 | $4,113,000 | -10.9% | 50,293 | -0.5% | 0.17% | -15.9% |
| Q2 2021 | $4,614,000 | +7.6% | 50,567 | +0.8% | 0.21% | +1.0% |
| Q1 2021 | $4,288,000 | -8.1% | 50,159 | +1.5% | 0.20% | -14.9% |
| Q4 2020 | $4,668,000 | +7.5% | 49,434 | -1.0% | 0.24% | -6.9% |
| Q3 2020 | $4,341,000 | -0.2% | 49,917 | +0.2% | 0.26% | -9.1% |
| Q2 2020 | $4,351,000 | +6.6% | 49,820 | +0.6% | 0.28% | -8.7% |
| Q1 2020 | $4,082,000 | -9.3% | 49,512 | +4.1% | 0.31% | +13.0% |
| Q4 2019 | $4,502,000 | +8.7% | 47,540 | -0.2% | 0.28% | +5.7% |
| Q3 2019 | $4,141,000 | -5.0% | 47,652 | -0.2% | 0.26% | -6.8% |
| Q2 2019 | $4,360,000 | -5.9% | 47,746 | -0.9% | 0.28% | -9.7% |
| Q1 2019 | $4,632,000 | +12.5% | 48,182 | +0.5% | 0.31% | -1.0% |
| Q4 2018 | $4,116,000 | -1.7% | 47,965 | -1.3% | 0.31% | +9.8% |
| Q3 2018 | $4,188,000 | +14.8% | 48,602 | +0.6% | 0.28% | +7.5% |
| Q2 2018 | $3,649,000 | -3.3% | 48,310 | +3.5% | 0.26% | -6.7% |
| Q1 2018 | $3,774,000 | -2.8% | 46,678 | +0.9% | 0.28% | +0.4% |
| Q4 2017 | $3,884,000 | -2.9% | 46,259 | -0.7% | 0.28% | -10.2% |
| Q3 2017 | $4,000,000 | +5.9% | 46,589 | +2.9% | 0.32% | 0.0% |
| Q2 2017 | $3,778,000 | +11.7% | 45,266 | -0.6% | 0.32% | +5.4% |
| Q1 2017 | $3,381,000 | +6.2% | 45,520 | +4.1% | 0.30% | +2.7% |
| Q4 2016 | $3,184,000 | -5.4% | 43,715 | +2.6% | 0.29% | -17.6% |
| Q3 2016 | $3,364,000 | +1.1% | 42,598 | +5.6% | 0.35% | -5.1% |
| Q2 2016 | $3,329,000 | +13.2% | 40,342 | -0.6% | 0.37% | +8.8% |
| Q1 2016 | $2,940,000 | -15.8% | 40,592 | 0.0% | 0.34% | -21.7% |
| Q4 2015 | $3,493,000 | +0.5% | 40,592 | +7.4% | 0.44% | -8.0% |
| Q3 2015 | $3,475,000 | -0.7% | 37,808 | +6.3% | 0.48% | +7.0% |
| Q2 2015 | $3,499,000 | -2.0% | 35,581 | -1.7% | 0.44% | -1.3% |
| Q1 2015 | $3,569,000 | +7.9% | 36,194 | +1.4% | 0.45% | +9.0% |
| Q4 2014 | $3,307,000 | -1.2% | 35,695 | +0.4% | 0.41% | -7.2% |
| Q3 2014 | $3,347,000 | +4.6% | 35,560 | +0.6% | 0.44% | +4.5% |
| Q2 2014 | $3,199,000 | +4.6% | 35,336 | -1.7% | 0.43% | -0.2% |
| Q1 2014 | $3,057,000 | +13.4% | 35,962 | +7.3% | 0.43% | +10.1% |
| Q4 2013 | $2,695,000 | +5.4% | 33,530 | +0.6% | 0.39% | -4.4% |
| Q3 2013 | $2,557,000 | -11.3% | 33,328 | -18.2% | 0.41% | -8.6% |
| Q2 2013 | $2,882,000 | – | 40,752 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |